Single-Center Experience of a Triple Drug Prophylaxis Regimen for Sinusoidal Obstructive Syndrome (SOS) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
Sign Up to like & getrecommendations! Published in 2019 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2018.12.362
Abstract: Purpose Hepatic veno-occlusive disease (VOD) or SOS is a serious and potentially fatal complication of HSCT. Due to the limited amount of data regarding prophylactic agents for VOD, the goal of this study is to… read more here.
Keywords: patient; vod; undergoing allogeneic; patients undergoing ... See more keywords
Effect of pre-transplantation serum ferritin on outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000010310
Abstract: Background: Pre-transplantation serum ferritin (SF) has been considered to be a potential prognostic biomarker in patients undergoing allogeneic hematopoietic stem cell transplantation (allogeneic HSCT), but this conclusion remains controversial. Thus, we performed a meta-analysis to… read more here.
Keywords: undergoing allogeneic; pre transplantation; patients undergoing; transplantation serum ... See more keywords
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six‐year cohort analysis
Sign Up to like & getrecommendations! Published in 2020 at "Mycoses"
DOI: 10.1111/myc.13232
Abstract: Patients undergoing allogeneic stem cell transplantation (aSCT) are at high risk to develop an invasive fungal disease (IFD). Optimisation of antifungal prophylaxis strategies may improve patient outcomes and reduce treatment costs. read more here.
Keywords: undergoing allogeneic; cell transplantation; patients undergoing; antifungal prophylaxis ... See more keywords
A Simple Prognostic System in Myelofibrosis Patients Undergoing Allogeneic Stem Cell Transplant: A CIBMTR/EBMT analysis.
Sign Up to like & getrecommendations! Published in 2023 at "Blood advances"
DOI: 10.1182/bloodadvances.2023009886
Abstract: To develop a prognostic model for patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT) for myelofibrosis (MF). We examined 623 patients undergoing allo-HCT between 2000 - 2016 in the USA (CIBMTR cohort). A Cox multivariable… read more here.
Keywords: stem cell; undergoing allogeneic; patients undergoing; cibmtr ebmt ... See more keywords
Socioeconomic and clinical predictors of 30-day readmissions in AML patients undergoing allogeneic stem cell transplantation.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.6548
Abstract: 6548 Background: 30-day readmissions among acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT) are a key quality metric, contributing to morbidity, mortality, and healthcare costs. We analyzed age-specific characteristics and factors associated… read more here.
Keywords: undergoing allogeneic; cell transplantation; stem cell; day ... See more keywords